These eligibility criteria are similar to those used for Semaglutide and reflect FDA-approved indications for obesity treatment
Wegovy commonly causes nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, especially when starting treatment or increasing doses
CJC-1295 and Ipamorelin influence growth hormone pathways, which may affect body composition and metabolic processes
She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audiobook production and podcasting)
The 0.5mg assessment dose at the beginning is particularly valuable for researchers who have never used any incretin-based peptide before, as it reveals individual sensitivity before committing to the standard 1mg starting dose
In an animal study conducted on rodents, Gabery et al